Topics
Glioblastoma | Treatment | Immunotherapy | Vaccines
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Vaccines
*Xiong Z, Raphael I, Olin M, Okada
H, Li X, Kohanbash G.
Glioblastoma
vaccines: past, present, and opportunities.
EBioMedicine.
2024 Jan 5;100:104963. doi:
10.1016/j.ebiom.2023.104963. PMID:
38183840. Review. ˍ
Galanis E, Dooley KE, Keith
Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ,
Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson
SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC,
Giannini C, Raghunathan A, Iankov ID, Parney IF.
Carcinoembryonic
antigen-expressing oncolytic measles virus derivative in recurrent
glioblastoma: a phase 1 trial.
Nat
Commun. 2024 Jan
12;15(1):493. doi:
10.1038/s41467-023-43076-7. PMID:
38216554. Interventional
study. ˍ
Squalli
Houssaini A, Lamrabet S, Nshizirungu JP, Senhaji N, Sekal M,
Karkouri M, Bennis S.
Glioblastoma
Vaccines as Promising Immune-Therapeutics: Challenges and Current
Status.
Vaccines
(Basel).
2024 Jun 12;12(6):655. doi:
10.3390/vaccines12060655. PMID:
38932383.
Review. ˍ
Dillman RO, Bota DA.
Next-generation
vaccines are showing promise against glioblastoma.
Oncotarget.
2024 Aug 5;15:543-548. doi:
10.18632/oncotarget.28636. PMID:
39102214. Editorial. ˍ
Latzer P, Zelba H, Battke F, Reinhardt A, Shao B, Bartsch O,
Rabsteyn A, Harter J, Schulze M, Okech T, Golf A, Kyzirakos-Feger
C, Kayser S, Pieper N, Feldhahn M, Wünsche J, Seitz C,
Hadaschik D, Garbe C, Hauser TK, la Fougère C, Biskup D,
Brooke D, Parker D, Martens UM, Illerhaus G, Blumenthal DT,
Merrell R, Lorenzo LS, Hidvégi M, de Robles P, Kebir S, Li
WW, Li VW, Williams M, Miller AM, Kesari S, Castro M, Desjardins
A, Ashley DM, Friedman HS, Wen PY, Neil EC, Iwamoto FM, Sipos B,
Geletneky K, Zender L, Glas M, Reardon DA, Biskup S.
A
real-world observation of patients with glioblastoma treated with
a personalized peptide vaccine.
Nat
Commun. 2024 Aug 11;15(1):6870. doi:
10.1038/s41467-024-51315-8. PMID:
39127809. Observational
study. ˍ
Strika Z, Petković K, Likić R.
Effectiveness
and Safety of mRNA Vaccines in the Therapy of Glioblastoma.
J
Pers Med. 2024 Sep 19;14(9):993. doi:
10.3390/jpm14090993. PMID:
39338247. Perspective. ˍ
Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I,
Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar
A.
Personalized mRNA vaccines in
glioblastoma therapy: from rational design to clinical trials.
J
Nanobiotechnology. 2024 Oct 4;22(1):601. doi:
10.1186/s12951-024-02882-x. PMID:
39367418. Review. ˍ
Tapescu I, Madsen PJ, Lowenstein PR, Castro MG, Bagley SJ, Fan Y,
Brem S.
The transformative potential
of mRNA vaccines for glioblastoma and human cancer: technological
advances and translation to clinical trials.
Front
Oncol. 2024 Sep 27;14:1454370. doi:
10.3389/fonc.2024.1454370. PMID:
39399167. Review. ˍ
Tabatabai G, Platten M, Preusser M, Weller M, Wick W, van den Bent
M.
Treatment of glioblastoma patients
with personalized vaccines outside clinical
trials: Lessons ignored?
Neuro
Oncol. 2024 Nov 19:noae225. doi:
10.1093/neuonc/noae225. PMID:
39561243. Comment. ˍ
REFERS
TO:
Latzer P, Zelba H, Battke F, Reinhardt A, Shao B,
Bartsch O, Rabsteyn A, Harter J, Schulze M, Okech T, Golf A,
Kyzirakos-Feger C, Kayser S, Pieper N, Feldhahn M, Wünsche J,
Seitz C, Hadaschik D, Garbe C, Hauser TK, la Fougère C,
Biskup D, Brooke D, Parker D, Martens UM, Illerhaus G, Blumenthal
DT, Merrell R, Lorenzo LS, Hidvégi M, de Robles P, Kebir S,
Li WW, Li VW, Williams M, Miller AM, Kesari S, Castro M,
Desjardins A, Ashley DM, Friedman HS, Wen PY, Neil EC, Iwamoto FM,
Sipos B, Geletneky K, Zender L, Glas M, Reardon DA, Biskup S.
A
real-world observation of patients with glioblastoma treated with
a personalized peptide vaccine.
Nat
Commun.
2024 Aug 11;15(1):6870. doi:
10.1038/s41467-024-51315-8. PMID:
39127809. Observational
study.
ˍ